METHIMAZOLE AND CARBIMAZOLE IN HYPERTHYROIDISM
- 1 July 1959
- journal article
- research article
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 238 (1) , 1-12
- https://doi.org/10.1097/00000441-195907000-00001
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- CLINICAL EXPERIENCES WITH CARBIMAZOLE (1-METHYL-2-CARBETHOXY-THIO-IMIDAZOLE) IN THE TREATMENT OF HYPERTHYROIDISMJournal of Clinical Endocrinology & Metabolism, 1956
- A FOUR-YEAR STUDY OF THE TREATMENT OF HYPERTHYROIDISM WITH METHIMAZOLE*Journal of Clinical Endocrinology & Metabolism, 1954
- CLINICAL EXPERIENCE WITH A NEW ANTITHYROID DRUG: 2-CARBETH0XYTHI0-1-METHYLGLYOX ALINE*†Journal of Clinical Endocrinology & Metabolism, 1953
- THERAPEUTIC STUDIES IN HYPERTHYROIDISM: METHIMAZOLEJournal of Clinical Endocrinology & Metabolism, 1952
- PRE-OPERATIVE USE OF, AND HISTOLOGICAL CHANGES PRODUCED BY TAPAZOLE1951